Animal Models of Human Disease

Biomere has evaluated a range of animal models for different disease areas, including obesity, cardiovascular disease, diabetes, autoimmune disease, hemophilia, kidney disease, skin conditions and ocular disease. Our team is continuously testing models of disease states, and collaborates with drug developers to use new models for preclinical PK/PD, efficacy and early toxicology studies. Contact us to discuss your study needs.

Animal Models of Metabolic Disease

Obesity and related complications are of high interest, largely due to the clinical and commercial success of GLP-1-based therapies. As such, there is high interest in testing next-generation therapies in preclinical animal models. Metabolic disease models are typically classified into induced and engineered models – for example, diet is the primary stimulus to induce an obese phenotype, while genetically modified mice (such as ApoE variant mice) develop obesity when exposed to high fat diets.  

Obesity and related complications are of high interest, largely due to the clinical and commercial success of GLP-1-based therapies. As such, there is high interest in testing next-generation therapies in preclinical animal models. Metabolic disease models are typically classified into induced and engineered models – for example, diet is the primary stimulus to induce an obese phenotype, while genetically modified mice (such as ApoE variant mice) develop obesity when exposed to high fat diets.  

Biomere has experience working with the following models for obesity and related complications: 

Disease Indication

Model

Species

Obesity

Diet-Induced Obesity (DIO)

Mouse

OB/OB Mice

Mouse

Hyperlipidemia & Hypercholesteremia

High-Fat, High-Calorie (HFHC) Diet in ApoE Mice

 

Mouse

Atherosclerosis

Models of Diabetes and Diabetic Complications

Mouse models are widely used to study both type I and type II diabetes and related complications, and are either genetically engineered or induced. For example, Streptozotocin (STZ) destroys pancreatic beta-cells that produce insulin, mimicking type I diabetes. Type II diabetes models include ob/ob and db/db mice that are engineered to be leptin deficient and leptin receptor deficient, respectively. Since these mouse models recapitulate many hallmarks of diabetes, they are used to study related complications, such as delayed wound healing and kidney damage. More recently, these models are being used to study protective effects of GLP-1 therapies.

Biomere has evaluated the following models for diabetes and related complications:   

Disease Indication

Model

Species

Type I Diabetes Mellitus

STZ-Induced Diabetes

Mouse, Rat

Type II Diabetes Mellitus

OB/OB Mice

Mouse

DB/DB Mice

Mouse

Zucker Diabetic Fatty (ZDF) Rat

Rat

Diabetic Nephropathy

STZ Induction +Nephrectomy + High Salt Load

Mouse, Rat

Delayed Diabetic Wound Healing

STZ Induction (Type I Diabetes) + Skin Excision

Rat

Type II Diabetes (DB/DB Mouse or ZDF Rat) + Skin Excision

Mouse, Rat

On This Page

Animal Models of Autoimmune Disease

Rodent models of autoimmune disease are valuable tools to understand disease onset and development, and evaluate changes in the immune system, such as the development of autoantibodies and activated lymphocytes. While there are about 100 identified autoimmune diseases, Biomere has evaluated rodent models for commonly studied diseases listed below:

Disease Indication

Model

Species

Rheumatoid Arthritis

CFA (Complete Freund’s Adjuvant) Induced Arthritis

Mouse, Rat

Collagen Induced Arthritis

Mouse, Rat

Systemic Lupus Erythematosus (SLE)

MRL/Lpr mice that combines a spontaneous strain (MRL) and Fas mutation

Mouse

Graft vs Host Disease (GvHD)

PBMC Transplants in Immune-Deficient Mice

Mouse

Ulcerative Colitis

TNBS-Induced Colitis

Rat

DSS (Dextran Sulfate Sodium) Induced Colitis

Mouse

Psoriasis

Imiquimod Induced (topical application)

Mouse

Animal Models of Ocular Disease

Several animal species are commonly used to study ocular diseases, including rodents, rabbits, and primates. Primates are highly translational models because their ocular anatomy and physiology closely resemble those of humans and rabbits are also widely used in ocular research due to their large eye size and lack of tear ducts, which minimizes washout of topically applied drugs. In addition, rabbit eyes share similar tissue architecture and vascularization with human eyes. Disease-specific rodent models are valuable tools to study ocular diseases.  

Biomere has a dedicated ocular research team with extensive expertise in both topical and specialty dosing techniques, including subretinal, intravitreal, intracameral, and subconjunctival administration. The team continually develops and evaluates new ocular disease models using advanced qualitative and quantitative assessment methods, such as optical coherence tomography (OCT), fundus and corneal imaging, electroretinography (ERG), and visual evoked potential (VEP) recordings.

 

Disease Indication

Model

Species

Corneal Wound

Chemical or Mechanical Wounds

Rabbit

Choroidal Neovasculaturization (CNV)

Laser induced CNV

Mouse, Rat

Acute & Chronic Glaucoma

Silicon Oil Acute Glaucoma

Trabecular Meshwork Laser Chronic Glaucoma

Mouse, Primate

Dry AMD

Sodium Iodate

Rat

Retinal Neovascularization (RNV)

DL-AAA (DL-2-aminoadipic acid) Induced

Rabbit

Other Animal Models of Disease

Animal Models of Blood Disorders

Chemotherapy-induced blood disorders are commonly observed clinically, thus it is important to evaluate whether or not specific therapies induce blood disorders, such as anemia and thrombocytopenia. Additionally, mouse models, such as the Factor VIII knockout model, are used to evaluate if novel therapeutics, including viral and nonviral gene therapies, cause spontaneous bleeding or other blood issues. Biomere uses the F8KO model as well as multiple species to evaluate blood disorders caused by chemotherapeutic agents.

Disease Indication

Model

Species

Coagulation Disorders

Hemophilia in F8KO (Factor VIII) Mice

Mouse

Granuolocyte/Thrombocytopenia

Chemotherapy-Induced

Mouse

Anemia

Chemotherapy-Induced

Mouse, Rat 

Animal Models of Kidney Disease

Kidney disease can be induced through multiple methods, including surgery (5/6 nephrectomy), ischemia triggered by tubule damage, or drugs like cisplatin. Additionally, diabetic mouse models can be induced via surgical ablation to develop kidney disease. Biomere has validated large and small animal models for acute kidney injury and chronic kidney disease.

 

Disease Indication

Model

Species

Acute Kidney Injury

Granuolocyte/Thrombocytopenia

Unilateral Renal Ischemia and Eperfusion

Rat 

Cisplatin-Induced injury

Mouse, Rat

Chronic Kidney Disease

5/6 Nephrectomized

Rat

Animal Models of Skin Conditions

To study skin conditions, rodent and large animal models are popular preclinical models.  While swine are popular models for skin condition studies, due to similar tissue architecture, thickness and permeability as human skin, primate models can also be used for erythema studies.

Disease Indication

Model

Species

Wound Healing

Skin Excision

Mouse, Rat

Erythema

UV or Inflammation Induced Skin Redness

Primate

Frequently Asked Questions

Question

Answer

Blogs

Humanized Mouse Models for DMPK Studies

Chinese RDMPK (drug metabolism and pharmacokinetics) studies are a required part of any preclinical drug discovery program. Independent of the modality or disease area, it

Related Insights

Humanized Mouse Models for DMPK Studies

Chinese RDMPK (drug metabolism and pharmacokinetics) studies are a required part of any preclinical drug discovery program. Independent of the modality or disease area, it

Complete listing of disease models including specific models and species is available on The Concourse, or contact Deborah Curry at dcurry@biomere.com

Metabolic Disease Models

Indications

  • Obesity
  • Type 1 diabetes mellitus
  • Type 2 diabetes mellitus
  • Hyperlipidemia/Hypercholesterolemia
  • Atherosclerosis
  • Hyperuricemia

Diabetes Complications

Indications

  • Diabetic nephropathy
  • Delayed diabetic wound healing
  • Diabetic neuralgia

DIGESTIVE DISORDERS

DIGESTIVE DISORDERS

Indications

  • Acute gastric ulcer
  • Chronic gastric ulcer
  • Acute and chronic liver injury/fibrosis
  • Hepatic fibrosis/decompensated cirrhosis
  • Nonalcoholic fatty liver disease (NASH)

CNS – CENTRAL & PERIPHERAL NERVOUS SYSTEM DISEASES

Nerves

Indications

  • Alzheimer’s disease
  • Parkinson’s disease
  • Depression/Anxiety
  • Epilepsy
  • Sleep/Sedation/Anesthesia Induction
  • Pain
  • Stroke
  • Spinal Cord Injury (SCI)
  • Drug dependence
  • Migraine
  • Somatic neurotoxicity

INFLAMMATION & AUTOIMMUNE DISEASE

Indications

  • Rheumatoid arthritis
  • Systemic lupus erythematosus (SLE) model
  • GvHD
  • Ulcerative colitis
  • EAE
  • Psoriasis
  • Atopic dermatitis models
    Sepsis

Blood Disorders

Indications

  • Coagulation disorders
  • Granulocyte/thrombocytopenia
  • Anemia

INFECTIOUS DISEASE

infectious disease

Indications

  • Influenza
  • HBV infection

ENDOCRINE DISEASE

Indications

  • Osteoporosis

REPRODUCTIVE SYSTEM DISEASE

Indications

  • Asthenospermia
  • Primary ovarian insufficiency

UROLOGIC DISEASES

Indications

  • Acute kidney injury
  • Chronic kidney disease/renal fibrosis

DERMAL

Indications

  • Wound healing
  • Burn

Complete listing of pharmacology models, including specific models and species is available on The Concourse, or contact Deborah Curry at dcurry@biomere.com

Our global liaison team paves the way to extended resources, abundant pharmacology models and budget friendly options seamlessly.